Finance

Beta
Lists
KPL:NSE
Kwality Pharmaceuticals Ltd
₹2,314.80
-1.29%
(-30.30) 1D
Jun 4, 12:20:59 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KPL...
Open
₹2,354.00
High
₹2,375.00
Low
₹2,300.00
Mkt. cap
24.02B
Avg. vol.
45.59K
Volume
9.11K
P/E ratio
35.67
52-wk high
₹2,388.00
52-wk low
₹1,561.00
EPS
₹64.90
No. of employees
997
Open
₹2,354.00
High
₹2,375.00
Low
₹2,300.00
Mkt. cap
24.02B
Avg. vol.
45.59K
Volume
9.11K
P/E ratio
35.67
52-wk high
₹2,388.00
52-wk low
₹1,561.00
EPS
₹64.90
No. of employees
997
News stories
From sources across the web
About Kwality Pharmaceuticals Ltd
CEO-
Employees997
Founded1983
Headquarters-
SectorPharmaceutical industry
Websitekwalitypharma.com
Last report
May 19, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.57B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.11B
1.11B
1.23B
1.57B
Cost of goods sold
580.34M
546.25M
590.97M
866.79M
Cost of revenue
580.34M
546.25M
590.97M
866.79M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
121.55M
133.13M
143.58M
142.17M
Operating expense
336.58M
351.33M
386.86M
358.80M
Total operating expenses
916.91M
897.58M
977.83M
1.23B
Operating income
197.88M
212.93M
256.56M
345.55M
Other non operating income
-1.00K
-1.00K
-1.00K
-
EBT including unusual items
170.28M
184.50M
223.45M
316.68M
EBT excluding unusual items
170.28M
184.50M
231.75M
316.68M
Income tax expense
51.08M
43.35M
63.45M
63.58M
Effective tax rate
30.00%
23.49%
28.40%
20.08%
Other operating expenses
167.38M
168.61M
195.06M
163.99M
Net income
119.26M
141.16M
160.09M
253.01M
Net profit margin
10.70%
12.71%
12.97%
16.10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-27.60M
-28.42M
-24.82M
-28.87M
Net interest expenses
-27.60M
-28.42M
-24.82M
-28.87M
Depreciation and amortization charges
47.65M
49.60M
48.22M
52.64M
EBITDA
243.60M
261.55M
302.29M
395.08M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer